Researchers Say NIPT Has Limited Clinical Utility for Subchromosomal Abnormalities | GenomeWeb

NEW YORK (GenomeWeb) – Noninvasive prenatal testing has limited clinical utility for subchromosomal abnormalities, according to a team of UK-based researchers.

As the popularity of NIPT tests  for detecting fetal aneuploidies like trisomies 21, 18, and 13 has risen, commercial providers have moved to expand their offerings to include recurrent microdeletions and microduplications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.